Watch OSRHW. Know when insiders buy.
One email the day a filing lands. Free.
OSRHW
OSR Health, Inc.
0.01
+0.00 +0.00%
USD · close Sep 24
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
45
WATCH · shorts 45
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $351KP/E —DIV YIELD —FCF YIELD —REV TTM $1.8M −50.2%NET INCOME −$14.9MNET DEBT $2.7M52W 0.01 – 0.03SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $316K | −72.2% | 27.4% | −$3M | −$1M | — | -0.02 | −$2.4M | — | — | Aug 14 |
| Q1 2026 · Mar 31 | $484K | −36.4% | 33.1% | −$3.7M | −$3.5M | — | -0.08 | −$1M | — | — | Aug 14 |
| Q4 2025 · Dec 31derived | $381K | −58.3% | 34.0% | −$6.4M | −$7.2M | — | -0.23 | −$1.1M | — | — | Mar 31 |
| Q3 2025 · Sep 30 | $628K | −23.7% | 41.7% | −$3.8M | −$3.2M | — | -0.10 | −$2.7M | — | — | Nov 12 |
| Q2 2025 · Jun 30 | $1.1M | — | 2.9% | −$5.2M | −$5.2M | — | 0.02 | −$483K | — | — | Aug 14 |
| Q1 2025 · Mar 31 | $761K | — | 22.2% | −$2.9M | −$11.4M | — | -1.04 | −$64K | — | — | Aug 14 |
| Q4 2024 · Dec 31derived | $915K | — | 17.5% | −$1.6M | −$2M | — | -0.62 | −$181K | — | — | Mar 31 |
| Q3 2024 · Sep 30 | $823K | — | 21.8% | −$3.6M | −$231K | −395.4% | -0.06 | −$686K | — | — | Nov 12 |
| Q2 2024 · Jun 30 | — | — | — | −$3.2M | −$97K | — | -0.02 | −$483K | — | — | Aug 14 |
| Q1 2024 · Mar 31 | — | — | — | −$3.3M | −$60K | — | -0.01 | −$499K | — | — | May 20 |
| Q4 2023 · Dec 31derived | — | — | — | — | −$86K | — | 0.02 | −$279K | — | — | Apr 22 |
| Q3 2023 · Sep 30 | — | — | — | — | $78K | — | 0.01 | −$143K | — | — | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $2.9M | 20.4% | −$18.3M | −$27.1M | -931.2% | -0.80 | −$4.3M | — | — | — | — |
| FY2024 · to Dec 31 | $3.5M | 23.0% | −$11.7M | −$2.4M | -68.3% | -4.79 | −$1.8M | — | — | $36.2M | — |
| FY2023 · to Dec 31 | — | — | −$1.8M | $404K | — | 0.05 | −$819K | — | — | $36M | — |
| FY2022 · to Dec 31 | — | — | −$35K | −$35K | — | -0.01 | −$4K | — | — | — | — |
| FY2021 · to Dec 31 | — | — | −$3K | −$3K | — | 0.00 | −$461 | — | — | — | — |
Every number comes from OSR Health, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.